nib holdings (ASX:NHF) has provided an update on its expected non-recurring expenses for the first half of FY26, ahead of the period's close.
The health insurer expects non-recurring cash expenses of approximately $17 million, higher than previously indicated at its FY25 results briefing, compared with $21.5 million in FY25, which included M&A and integration costs.
Around $8 million of this relates to historical adjustments for the Private Health Insurance Australian Government Rebate and the NSW Hospital Insurance Levy, with nib adjusting its approach following government clarifications and recent legal determinations.
Additional cash costs stem from restructuring under its group-wide productivity program and strategic initiatives, including a review of nib Travel.
Non-cash expenses of about $4.5 million are expected for the write-down of redundant software acquired through nib Thrive's NDIS-related acquisitions, reflecting the consolidation of multiple businesses onto a single technology platform.
Despite these one-off items, nib's group underlying operating profit for H1 FY26 continues to track expectations, pending the second-quarter risk equalisation outcome.
The company will release its H1 FY26 results on Feb. 23, 2026.